Want to join the conversation?
During 4Q15, $INTC total cash investments were $25.3Bil, which up $4.5Bil from 3Q15 and $11.1Bil of the total $25.3Bil total cash investments is held by non-U.S. subsidiaries. During the reported quarter, cash flow from operations was $5.4Bil.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.